» Articles » PMID: 10669071

A Comparison of the Harms Associated with the Injection of Heroin and Amphetamines

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2000 Feb 11
PMID 10669071
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

An investigation into whether or not the level of harm associated with injecting drug use varies depending on the drug that is injected was conducted among 151 primary heroin injectors and 145 primary amphetamine injectors. Compared to primary amphetamine injectors, primary heroin injectors were more dependent on their primary drug, had poorer social functioning, and had recently exhibited a higher degree of criminal behaviour. There were no differences between the two groups in terms of the prevalence of needle sharing, their health, or their psychological functioning, despite the amphetamine users being significantly younger and having used less frequently. It is concluded that while there are some harms that are attributable to injecting per se, the type of drug that is injected does play a mediating role in the relationship between injecting drug use and its associated harm.

Citing Articles

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal.

Acheson L, Ezard N, Lintzeris N, Dunlop A, Brett J, Rodgers C PLoS One. 2022; 17(10):e0275371.

PMID: 36190973 PMC: 9529099. DOI: 10.1371/journal.pone.0275371.


Methamphetamine use and HIV risk behavior among men who inject drugs: causal inference using coarsened exact matching.

Noroozi M, Higgs P, Noroozi A, Armoon B, Mousavi B, Alikhani R Harm Reduct J. 2020; 17(1):66.

PMID: 32957982 PMC: 7507738. DOI: 10.1186/s12954-020-00411-1.


Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.

Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P Lancet Glob Health. 2017; 5(12):e1192-e1207.

PMID: 29074409 PMC: 5683738. DOI: 10.1016/S2214-109X(17)30375-3.


Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study.

Iversen J, Wand H, Topp L, Kaldor J, Maher L Am J Public Health. 2013; 103(8):1436-44.

PMID: 23763399 PMC: 4007859. DOI: 10.2105/AJPH.2012.301206.


Difficulty accessing syringes mediates the relationship between methamphetamine use and syringe sharing among young injection drug users.

Marshall B, Shoveller J, Wood E, Patterson T, Kerr T AIDS Behav. 2011; 15(7):1546-53.

PMID: 21197598 PMC: 3180618. DOI: 10.1007/s10461-010-9876-8.